ESMO 2016

Andreas Ullrich Discusses the Progress of Patient Access to Essential Medications – Parts 1 and 2

1.14.17 | FILED UNDER ESMO 2016, Vital Conversations
Posted by


Anita Waldmann Discusses Myelodysplastic Syndromes & Recent Changes in Patient Advocacy – Parts 1 – 4

1.14.17 | FILED UNDER ESMO 2016, Vital Conversations
Posted by


Christian Dittrich Discusses the Inclusion of Patients in all Phases of Clinical Trials – Parts 1 and 2

1.14.17 | FILED UNDER ESMO 2016, Vital Conversations
Posted by

 


  1. 1
  2. 2
  3. 3

Vital Options International provides this information and content in order to create awareness, educate, and generate discussions with healthcare providers. This information is not a substitute for the medical care and advice you receive from your own professional medical team. Vital Options International recommends that you consult with your doctor or other healthcare professional about the information presented to determine its relevance for your care.